TC
LRMR icon

TFS Capital’s Larimar Therapeutics LRMR Stock Holding History

TFS Capital’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,237
Closed -$178K – 205
2017
Q2 		$178K Buy
4,237
+3,363
+385% +$172K 0.07% 472
2017
Q1 		$49K Sell
874
-780
-47% -$38.7K 0.02% 626
2016
Q4 		$63K Sell
1,654
-408
-20% -$16.5K 0.02% 671
2016
Q3 		$82K Buy
2,062
+726
+54% +$33K 0.02% 679
2016
Q2 		$96K Buy
+1,336
New +$106K 0.02% 860
2015
Q3 		– Sell
-10,385
Closed -$4.32M – 982
2015
Q2 		$4.32M Buy
10,385
+8,350
+410% +$3.49M 0.42% 44
2015
Q1 		$967K Buy
+2,035
New +$966K 0.09% 357

Other funds holding LRMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return